Özcan, M., Cassaday, R. D., Zarzycka, E., Vandendries, E., Zhang, F., Chen, Y., . . . Altuntas, F. Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: A phase IV study. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationÖzcan, Muhit, et al. Efficacy and Safety of Currently Approved and Lower Starting Doses of Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: A Phase IV Study. Ferrata Storti Foundation.
MLA (9th ed.) CitationÖzcan, Muhit, et al. Efficacy and Safety of Currently Approved and Lower Starting Doses of Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: A Phase IV Study. Ferrata Storti Foundation.